More on KSIOF
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.60 |
|
|||
| Open | $4.62 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $4.62 | ||||
| Day Low | $4.62 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 2,744 | ||||
- Shareholders Overwhelmingly Approve Transaction with Thoma Bravo
- Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Kneat Shareholders Vote “FOR” the Thoma Bravo Transaction
- Thoma Bravo to acquire Kneat for C$650 million in all-cash deal
- Kneat Enters into Definitive Agreement to be Acquired by Thoma Bravo in an All-Cash Transaction, Valuing Kneat at Approximately C$650 Million
- Kneat.com Responds to Press Report
- 2026 State of Validation Study Reveals Significant Headroom Remains for Further Digitization
- Kneat to Announce 2026 First-Quarter Financial Results May 13, 2026
- Presenting on Emerging Growth Conference 91 Day 1 on April 1; Register to live stream
- Global Pharmaceutical Packaging Manufacturer Selects Kneat
- Kneat to Announce 2025 Fourth-Quarter and Year-End Financial Results February 25, 2026
Entities mentioned with KSIOF
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- CIBC | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
